← SynDRA
GLEMANSERIN
SynDRA canonical compound SYN0001133 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | HTR2A |
| Mechanism of action | Serotonin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR2A ANTAGONIST
- HTR2B ANTAGONIST
- HTR2C ANTAGONIST
- HTR2A INHIBITOR
Cross-references
Synonyms
- Glemanserine
- Glemanserina
- MDL-11,939
- MDL-11939
- Mdl 11939
- alpha-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol
- Mdl-11,939
- Glemanserin [USAN:INN]
- CHEMBL18972
- 4-Piperidinemethanol, alpha-phenyl-1-(2-phenylethyl)-
- 4-Piperidinemethanol, alpha-phenyl-1-(2-phenylethyl)-, (+-)-
- (+-)-1-Phenethyl-alpha-phenyl-4-piperidinemethanol
- AC1L2GSP
- Glemanserin (USAN/INN)
- ( inverted exclamation markA)-1-phenethyl-a-phenyl-4-piperidinemethanol
- GTPL186
- SCHEMBL120012
- AC1Q771C
- DTXSID4042624
- CTK8D3348
- CHEBI:91790
- phenyl-[1-(2-phenylethyl)piperidin-4-yl]methanol
- X96LS7MC5Z
- GLEMANSERIN [INN]
- GLEMANSERIN [USAN]
- phenyl-(1-(2-phenylethyl)piperidin-4-yl)methanol
- glemanserinum
- RefChem:663072
- DTXCID2022624
- phenyl[1-(2-phenylethyl)piperidin-4-yl]methanol
- UNII-X96LS7MC5Z
- AXNGJCOYCMDPQG-UHFFFAOYSA-N
- phenyl-[1-(2-phenylethyl)-4-piperidyl]methanol
- orb1704378
- HMS3266L14
- HMS3411B04
- HMS3675B04
- HEA70378
- BDBM50004327
Look up GLEMANSERIN in the interactive SynDRA portal →